Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

NCT00173316 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00173316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00173316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2004
Completion date
June 30, 2005
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral cancer